$2.83
0.114.04%
Últ. Act.: Nov 4, 7:58 PM
Pulmonx (LUNG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pulmonx (LUNG) publicó su última previsión de octubre 27, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $90M - $92M para el período.
En comparación con la previsión anterior, Pulmonx mantenido redujo su previsión de ingresos desde un rango anterior de $90M - $92M.
Pulmonx ha emitido 18 actualizaciones de orientación entre el febrero 22, 2023 y el octubre 27, 2026. During this period, the company raised its outlook 5 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.26 | $-0.28 | $-0.33 | $-0.39 |
| Actual | $-0.19 | $-0.24 | $-0.33 | $-0.25 |
| Surprise | +26.9% | +14.3% | 0.00% | +35.9% |
| Revenue | ||||
| Estimate | $22.0M | $22.4M | $20.4M | $21.7M |
| Actual | $22.8M | $22.8M | $20.6M | $22.6M |
| Surprise | +4.00% | +1.76% | +1.10% | +3.98% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.22 | $-0.26 | $-0.23 | $-0.20 |
| Revenue | ||||
| Consensus | $24.9M | $22.6M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $-0.19 | $-0.26 | 26.9 % |
| Q2 | Jul 29, 2026 | $-0.24 | $-0.28 | 14.3 % |
| Q1 | Apr 29, 2026 | $-0.33 | $-0.33 | 0.00 % |
| Q4 | Mar 4, 2026 | $-0.25 | $-0.39 | 35.9 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $22.84M | $21.96M | 4.00 % |
| Q2 | Jul 29, 2026 | $22.76M | $22.36M | 1.76 % |
| Q1 | Apr 29, 2026 | $20.59M | $20.36M | 1.10 % |
| Q4 | Mar 4, 2026 | $22.60M | $21.73M | 3.98 % |